Angiotensin-(1-7) receptor Mas is an essential modulator of extracellular matrix protein expression in the heart.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Regulatory Peptides

• Publication date

  2012-04-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.regpep.2012.01.001PMID 22285513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiotensin1‐9 antagonises pro‐hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor

  2011cited by this paper
• The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.

  2010cited by this paper
• Matrix metalloproteinases.

  2010cited by this paper
• Prevention of Pulmonary Hypertension by Angiotensin-Converting Enzyme 2 Gene Transfer

  2009cited by this paper
• Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts.

  2009cited by this paper
• Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.

  2009cited by this paper
• Angiotensin-(1–7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells

  2009cited by this paper
• Ablation of angiotensin (1-7) receptor Mas in C57Bl/6 mice causes endothelial dysfunction.

  2008cited by this paper
• Cardiac Overexpression of Angiotensin Converting Enzyme 2 Protects the Heart From Ischemia-Induced Pathophysiology

  2008cited by this paper
• Angiotensin‐(1–7) has a dual role on growth‐promoting signalling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II‐stimulated ERK1/2 and Rho kinase activity

  2008cited by this paper
• The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction.

  2007cited by this paper
• Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature

  2007cited by this paper
• Isoproterenol-induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin-(1-7) analogue AVE 0991.

  2007cited by this paper
• Angiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells

  2007cited by this paper
• Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension.

  2006cited by this paper
• Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice

  2006influential reference
• Matrix reloaded: the matrix metalloproteinase paradox.

  2006cited by this paper
• Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.

  2006cited by this paper
• Evidence for a Functional Interaction of the Angiotensin-(1–7) Receptor Mas With AT1 and AT2 Receptors in the Mouse Heart

  2005cited by this paper
• Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor.

  2005cited by this paper
• Angiotensin-(1–7) Acts as a Vasodepressor Agent Via Angiotensin II Type 2 Receptors in Conscious Rats

  2005cited by this paper
• Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects.

  2005cited by this paper
• Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene

  2004cited by this paper
• Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas

  2003cited by this paper
• Regulation of myocardial fibrillar collagen by angiotensin II. A role in hypertensive heart disease?

  2002cited by this paper
• Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats

  2002cited by this paper
• p38 MAP Kinase Regulates Vascular Smooth Muscle Cell Collagen Synthesis by Angiotensin II in SHR But Not in WKY

  2001cited by this paper
• Downregulation of the AT1A Receptor by Pharmacologic Concentrations of Angiotensin-(1-7)

  2001cited by this paper
• Angiotensin II Type 2 Receptor Is Essential for Left Ventricular Hypertrophy and Cardiac Fibrosis in Chronic Angiotensin II–Induced Hypertension

  2001cited by this paper
• Connective tissue and the heart. Functional significance and regulatory mechanisms.

  2000cited by this paper
• Matrix metalloproteinases: effectors of development and normal physiology.

  2000cited by this paper
• Altered heart rate and blood pressure variability in mice lacking the Mas protooncogene.

  2000cited by this paper
• Opposing actions of angiotensins on angiogenesis.

  1999cited by this paper
• Angiotensin-(1-7) reduces smooth muscle growth after vascular injury.

  1999cited by this paper
• Matrix Metalloproteinases*

  1999cited by this paper
• Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases.

  1998cited by this paper
• Sustained Long Term Potentiation and Anxiety in Mice Lacking theMas Protooncogene*

  1998cited by this paper
• Expression of type VI collagen in the developing mouse heart

  1998cited by this paper
• Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release.

  1997cited by this paper
• Matrix metalloproteinases

  1997cited by this paper
• Angiotensin-(1-7) inhibits vascular smooth muscle cell growth.

  1996cited by this paper
• Connective Tissue and Repair in the Heart

  1995cited by this paper
• Connective tissue and repair in the heart. Potential regulatory mechanisms.

  1995cited by this paper
• Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts.

  1995cited by this paper
• Expression of the mouse and rat mas proto‐oncogene in the brain and peripheral tissues

  1995cited by this paper
• Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.

  1994cited by this paper
• Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen.

  1992influential reference
• Matrix metalloproteinases and their inhibitors in connective tissue remodeling

  1991cited by this paper
• Cardiac interstitium in health and disease: the fibrillar collagen network.

  1989cited by this paper
• Collagen metabolism in the myocardium of normal and diabetic rats.

  1988cited by this paper
• Physiologic Versus Pathologic Hypertrophy and the Pressure‐Overloaded Myocardium

  1987cited by this paper
• Collagen synthesis and degradation in vivo. Evidence for rapid rates of collagen turnover with extensive degradation of newly synthesized collagen in tissues of the adult rat.

  1987cited by this paper
• Skeletal framework of mammalian heart muscle. Arrangement of inter- and pericellular connective tissue structures.

  1983cited by this paper
• Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections

  1979cited by this paper

• Class A Orphans in GtoPdb v.2025.1

  2025cites this paper
• Class A Orphans in GtoPdb v.2025.4

  2025cites this paper
• MAS RECEPTOR BLOCKADE IMPAIRS EXERCISE-INDUCED CARDIAC HYPERTROPHY.

  2024cites this paper
• Novel Insights into the Cardioprotective Effects of the Peptides of the Counter-Regulatory Renin–Angiotensin System

  2024cites this paper
• Insights into Cardiovascular Defects and Cardiac Epigenome in the Context of COVID-19

  2022cites this paper
• G protein-coupled receptor Mas induces an inhibitory effect on myocardial infarction-induced myocardial injury.

  2022cites this paper
• Class A Orphans in GtoPdb v.2021.3

  2021cites this paper
• World Journal of Gastroenterology From to of via the gut-liver-brain axis in

  2020cites this paper
• Cirrhotic portal hypertension: From pathophysiology to novel therapeutics

  2020cites this paper
• Participation of Gαi-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways

  2019cites this paper
• Heart – Coronary Vessels and Cardiomyocytes

  2019cites this paper
• Angiotensin-(1-7) and the Heart

  2019cites this paper
• Angiotensin (1-7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor.

  2018cites this paper
• Renin angiotensin system and different mediators induce renal fibrosis

  2018cites this paper
• Angiotensin-converting enzyme 2 and its potential protective effect upon heart

  2018cites this paper
• Angiotensin‐converting enzyme 2–Angiotensin 1‐7/1‐9 system: novel promising targets for heart failure treatment

  2018cites this paper
• The antioxidant and anti-inflammatory properties of lycopene in mice lungs exposed to cigarette smoke.

  2017cites this paper
• The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)

  2017cites this paper
• Cardioprotective effects of angiotensin converting Enzyme II

  2017cites this paper
• Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy

  2017cites this paper
• Effects of ACE 2-Ang ( 1-7 )-Mas axis on primary myocardial cell apoptosis : an in vitro study

  2017cites this paper
• Differential effects of Mas receptor deficiency on cardiac function and blood pressure in obese male and female mice.

  2017influential citation
• Connective tissue growth factor dependent collagen gene expression induced by MAS agonist AR234960 in human cardiac fibroblasts

  2017cites this paper
• Swim training attenuates the adverse remodeling of LV structural and mechanical properties in the early compensated phase of hypertension☆

  2017cites this paper
• Plastid Molecular Pharming II. Production of Biopharmaceuticals by Plastid Transformation.

  2017cites this paper
• Protective role of ACE2-Ang-(1–7)-Mas in myocardial fibrosis by downregulating KCa3.1 channel via ERK1/2 pathway

  2016cites this paper
• ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.

  2016cites this paper
• Mas receptor contributes to pregnancy-induced cardiac remodelling.

  2016cites this paper
• Function of renin angiotensin system on heart failure

  2016cites this paper
• ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension

  2015cites this paper
• Mas and Inflammation

  2015cites this paper
• International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli

  2015cites this paper
• MAS C-Terminal Tail Interacting Proteins Identified by Mass Spectrometry- Based Proteomic Approach

  2015cites this paper
• Mas in Myocardial Infarction and Congestive Heart Failure

  2015cites this paper
• This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon.

  2014cites this paper
• Angiotensin-( 1-7 ) and angiotensin-( 1-9 ) : function in cardiac and vascular remodeling

  2014cites this paper
• Angiotensin (1–7) prevents angiotensin II‐induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice

  2014cites this paper
• Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling.

  2014cites this paper
• Angiotensin-(1-7).

  2014cites this paper
• New antihypertensive drugs under development.

  2014cites this paper
• Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation

  2014cites this paper
• Mas and Its Related G Protein–Coupled Receptors, Mrgprs

  2014cites this paper
• Atypical Signaling and Functional Desensitization Response of MAS Receptor to Peptide Ligands

  2014cites this paper
• Cholinergic Signaling Exerts Protective Effects in Models of Sympathetic Hyperactivity-Induced Cardiac Dysfunction

  2014cites this paper
• Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.

  2013cites this paper
• ACE2, angiotensin‐(1‐7) and Mas receptor axis in inflammation and fibrosis

  2013influential citation
• Opportunities for Targeting the Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Receptor Pathway in Hypertension

  2013cites this paper
• The ACE2/Ang-(1–7) Pathway in Cardiac Fibroblasts as a Potential Target for Cardiac Remodeling

  2013cites this paper
• Loss of angiotensin-converting enzyme 2 exacerbates myocardial injury via activation of the CTGF-fractalkine signaling pathway.

  2013cites this paper
• new players of the Renin Angiotensin System

  2012cites this paper
• ACE2, angiotensin-(1–7), and Mas: the other side of the coin

  2012cites this paper